DEVARTLab holds the 48th scientific conference towards better health to raise awareness about dangers of heart disease and its prevention
DEVARTLab, the leading company in the functional food and innovative pharmaceutical industries, organized its 48th conference "For A Better Quality of Life # 48", under title "Towards Better Health and maximum protection from cardiovascular diseases", in the presence of best group of eminent professors and in cooperation with ESMA Association (Egyptian Society of Metabolic Syndrome).
The activities of the Scientific meeting began with celebration of 6th October war anniversary and a review of military operations carried out by Egypt at that time to liberate Sinai land. The Islamic nation was also congratulated on the Prophet’s birthday
Then we continued the meeting by DEVARTLab vision review, which was admired by all audience including our eminent chairpersons, and the history of cardiology in Egypt
At the beginning of the scientific sessions, Prof. Dr. Ehab Salem, President of "ESMA" Association and Professor of Endocrinology at Zagazig University, spoke about the recent increase in atherosclerosis rates and how lifestyle is a major factor in increasing these rates, and he pointed out that treatment from the beginning of diagnosis is imperative, also he spoke about the role of Advochol 10 mg (rosuvastatin) from DEVARTLab products, and its effectiveness in controlling the levels of low-density lipids and triglycerides in the blood.
Prof. Dr. Ahmed Taj, Assistant Professor of Cardiology at Suez Canal University, emphasized the increase in arterial calcification rates in the last decade and the danger extent of calcium deposition on blood vessels’ wall and heart tissue in the deterioration of patients’ health who suffering from heart disease, atherosclerosis, diabetes and kidney disease.
He also addressed the role of Mena Q. “Vitamin K2” that protect patients, prevents calcium deposits on blood vessels’ wall and heart tissues, and reduces mortality rates resulting from arterial calcification, and its role in reducing the complications of atherosclerosis. He stressed the importance of using Mena Q with these cases to ensure that calcium is not deposited on blood vessels’ wall and to reduce the complications of atherosclerosis and the deterioration of disease.
Prof. Dr. Yasser Abdel-Galil, Professor of Cardiology at Al-Azhar Medicine, reviewed the rates of high blood pressure and the rates of heart failure that followed, and pointed out the importance of the role of the Nepvol product on lowering aortic blood pressure and its effective course with patients with heart failure.
Prof. Dr. Jamila Nasr, Professor of Cardiology at Suez Canal University and a member of Directors board of Egyptian Heart Association, pointed out that DEVARTLab introduced new and innovative solutions in the Egyptian pharmaceutical market, including "Mena Q", "Pharafero 18 and 18 Plus" and "Advochol". and "Nepvol".
Also, Dr. Ahmed Salah Shams, a kidney teacher at Zagazig University, spoke about the importance of the product “Pharafero 18 and 18 Plus” and that it is one of the best products in iron deficiency anemia management due to its effectiveness without side effects such as abdominal pain, constipation and other problems that exhausted the Egyptian patient who is looking for an optimum solution for iron deficiency anemia
Dr. Islam El-Shafei, sales manager at DEVARTLab, pointed out the company's vision and duty towards society by pumping products that serve the Egyptian patient, starting with the introduction of the Mena Q product for the first time in the Egyptian market, along with many other products that DEVARTLab will launch in the pharmaceutical market soon
More than 100 Doctors, Professors and Consultants of Cardiology, Internal Medicine, Diabetes and Nephrology from different Governorates all over Egypt have Attended the Conference